无症状与有症状的新型冠状病毒肺炎的传染性 - Suppr

Infectivity of asymptomatic versus symptomatic COVID-19.

作者信息

Sayampanathan Andrew A, Heng Cheryl S, Pin Phua Hwee, Pang Junxiong, Leong Teoh Yee, Lee Vernon J

机构信息

Ministry of Health, Singapore 169854.

出版信息

Lancet. 2021 Jan 9;397(10269):93-94. doi: 10.1016/S0140-6736(20)32651-9. Epub 2020 Dec 18.

DOI:10.1016/S0140-6736(20)32651-9

PMID:33347812

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7836843/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/727d/7836843/f2ba2e8d449d/fx1_lrg.jpg

相似文献

Infectivity of asymptomatic versus symptomatic COVID-19.

Lancet. 2021 Jan 9;397(10269):93-94. doi: 10.1016/S0140-6736(20)32651-9. Epub 2020 Dec 18.

Assessment of an Online Tool to Simulate the Effect of Pooled Testing for SARS-CoV-2 Detection in Asymptomatic and Symptomatic Populations.

JAMA Netw Open. 2020 Dec 1;3(12):e2031517. doi: 10.1001/jamanetworkopen.2020.31517.

Universal screening for novel coronavirus disease 2019 (COVID-19) for asymptomatic parturients: May not be beneficial at this time.

J Med Virol. 2021 Mar;93(3):1198-1200. doi: 10.1002/jmv.26507. Epub 2020 Sep 28.

Persistent viral infectivity after 27 days from COVID-19 symptoms onset.

J Clin Pathol. 2022 Mar;75(3):211-214. doi: 10.1136/jclinpath-2021-207394. Epub 2021 Jul 20.

Is the oral cavity a reservoir for prolonged SARS-CoV-2 shedding?

Med Hypotheses. 2021 Jan;146:110419. doi: 10.1016/j.mehy.2020.110419. Epub 2020 Nov 24.

SARS-CoV-2 transmission without symptoms.

Science. 2021 Mar 19;371(6535):1206-1207. doi: 10.1126/science.abf9569.

Comparison of Upper Respiratory Viral Load Distributions in Asymptomatic and Symptomatic Children Diagnosed with SARS-CoV-2 Infection in Pediatric Hospital Testing Programs.

J Clin Microbiol. 2020 Dec 17;59(1). doi: 10.1128/JCM.02593-20.

Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.

Virol J. 2021 Jun 12;18(1):126. doi: 10.1186/s12985-021-01597-x.

Mass testing for covid-19 in the UK.

BMJ. 2020 Nov 16;371:m4436. doi: 10.1136/bmj.m4436.

SARS-COV-2 and infectivity: Possible increase in infectivity associated to integrin motif expression.

J Med Virol. 2020 Oct;92(10):1741-1742. doi: 10.1002/jmv.25831. Epub 2020 Apr 10.

引用本文的文献

Beyond COVID-19: the promise of next-generation coronavirus vaccines.

Npj Viruses. 2024 Aug 22;2(1):39. doi: 10.1038/s44298-024-00043-3.

A novel framework for modeling quarantinable disease transmission.

PLoS One. 2025 Feb 12;20(2):e0317553. doi: 10.1371/journal.pone.0317553. eCollection 2025.

The Second Round of a Population-Based Seroprevalence Study of Anti-SARS-CoV-2 Antibodies and COVID-19 Vaccination Assessment in the Republika Srpska, Bosnia and Herzegovina.

Influenza Other Respir Viruses. 2025 Jan;19(1):e70053. doi: 10.1111/irv.70053.

Detection, linkage to care, treatment and monitoring of hypertension in coastal communities in Accra, Ghana: protocol for a quasi-experimental study (The Ghana Heart Initiative Hypertension Study).

BMJ Open. 2024 Nov 4;14(11):e082954. doi: 10.1136/bmjopen-2023-082954.

Retrospective estimation of the time-varying effective reproduction number for a COVID-19 outbreak in Shenyang, China: An observational study.

Medicine (Baltimore). 2024 May 31;103(22):e38373. doi: 10.1097/MD.0000000000038373.

The Impact of SIV-Induced Immunodeficiency on SARS-CoV-2 Disease, Viral Dynamics, and Antiviral Immune Response in a Nonhuman Primate Model of Coinfection.

Viruses. 2024 Jul 21;16(7):1173. doi: 10.3390/v16071173.

Breast cancer (BC) and severe COVID-19 (C-19) outcomes: a matched analysis.

Breast Cancer Res Treat. 2024 Jul;206(2):307-316. doi: 10.1007/s10549-024-07301-1. Epub 2024 Apr 6.

The effectiveness and efficiency of asymptomatic SARS-CoV-2 testing strategies for patient and healthcare workers within acute NHS hospitals during an omicron-like period.

BMC Infect Dis. 2024 Jan 8;24(1):64. doi: 10.1186/s12879-023-08948-9.

The role of asymptomatic infections in influenza transmission: what do we really know.

Lancet Infect Dis. 2024 Jun;24(6):e394-e404. doi: 10.1016/S1473-3099(23)00619-9. Epub 2023 Dec 18.

The Impact of SIV-Induced Immunodeficiency on Clinical Manifestation, Immune Response, and Viral Dynamics in SARS-CoV-2 Coinfection.

bioRxiv. 2023 Nov 16:2023.11.15.567132. doi: 10.1101/2023.11.15.567132.

本文引用的文献

Serology testing in the COVID-19 pandemic response.

Lancet Infect Dis. 2020 Sep;20(9):e245-e249. doi: 10.1016/S1473-3099(20)30517-X. Epub 2020 Jul 17.

Asymptomatic patients as a source of COVID-19 infections: A systematic review and meta-analysis.

Int J Infect Dis. 2020 Sep;98:180-186. doi: 10.1016/j.ijid.2020.06.052. Epub 2020 Jun 17.

A study on infectivity of asymptomatic SARS-CoV-2 carriers.

Respir Med. 2020 Aug;169:106026. doi: 10.1016/j.rmed.2020.106026. Epub 2020 May 13.

Connecting clusters of COVID-19: an epidemiological and serological investigation.

Lancet Infect Dis. 2020 Jul;20(7):809-815. doi: 10.1016/S1473-3099(20)30273-5. Epub 2020 Apr 21.

Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019.

Clin Infect Dis. 2020 Nov 19;71(16):2027-2034. doi: 10.1093/cid/ciaa344.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Infectivity of asymptomatic versus symptomatic COVID-19.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献